FIGURE 3.
Relapse‐free survival of FLT3‐mutated AML patients treated with post‐transplant FLT3i maintenance compared to controls.
Relapse‐free survival of FLT3‐mutated AML patients treated with post‐transplant FLT3i maintenance compared to controls.